Literature DB >> 30151712

Skewness of apparent diffusion coefficient (ADC) histogram helps predict the invasive potential of intraductal papillary neoplasms of the bile ducts (IPNBs).

Kai-Pu Jin1,2,3, Sheng-Xiang Rao1,2,3, Ruo-Fan Sheng1,2,3, Meng-Su Zeng4,5,6.   

Abstract

OBJECTIVE: This retrospective study was to explore the value of whole lesion apparent diffusion coefficient (ADC) histogram in distinguishing invasive and noninvasive intraductal papillary neoplasms of the bile ducts (IPNBs). METHOD AND MATERIALS: Fifty-two patients of IPNB underwent MRI at 1.5T with diffusion-weighted imaging (DWI, b = 500 s/mm2) before surgical resections. ADC histogram metrics were generated by using the software MR OncoTreat. The mean, standard deviation, median, skewness, kurtosis as well as the 10th, 25th, 75th, and 90th percentiles were compared between pathologically defined invasive (n = 35) and noninvasive (n = 17) IPNBs. Such conventional imaging characters as lesion location, bile duct wall dilation, and mural nodularity were also assessed. Multivariate regression analysis as well as receiver operating characteristics (ROC) analysis were then conducted to determine the predictive factors and to evaluate potential diagnostic performances.
RESULTS: The inter-operator reliability was good to excellent (ICC: 0.693-979). Mean median, kurtosis, and the 10th, 25th, 75th, 90th percentiles were all greater in noninvasive group than invasive ones (P: 0.00-002). Skewness was lower in noninvasive group than invasive ones (- 1.0 ± 0.6 vs. - 0.3 ± 0.6, P = 0.00). After multivariate regression, skewness (AUC = 0.822, 95%CI 0.70-0.91) and mural nodularity (accuracy = 0.808) were the only two independent factors in predicting invasive IPNBs. The diagnostic performance improved (AUC = 0.867, 95%CI 0.742-0.946) when combining skewness and mural nodularity, however, the difference did not reach statistical significance (P = 0.16).
CONCLUSION: The ADC histogram has capability of distinguishing invasive and noninvasive IPNBs, in which skewness was an independent predictive factor.

Entities:  

Keywords:  Bile duct neoplasms; Cholangiocarcinoma; Comparative study; Diffusion magnetic resonance imaging; Neoplasm invasiveness

Mesh:

Year:  2019        PMID: 30151712     DOI: 10.1007/s00261-018-1716-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas.

Authors:  Takahiro Komori; Dai Inoue; Yoh Zen; Norihide Yoneda; Azusa Kitao; Kazuto Kozaka; Akira Yokka; Fumihito Toshima; Takashi Matsubara; Satoshi Kobayashi; Toshifumi Gabata
Journal:  Eur Radiol       Date:  2018-12-05       Impact factor: 5.315

2.  Combining quantitative and qualitative magnetic resonance imaging features to differentiate anorectal malignant melanoma from low rectal cancer.

Authors:  Zeyan Xu; Ke Zhao; Lujun Han; Pinxiong Li; Zhenwei Shi; Xiaomei Huang; Chu Han; Huihui Wang; Minglei Chen; Chen Liu; Yanting Liang; Suyun Li; Yanqi Huang; Xin Chen; Changhong Liang; Wuteng Cao; Zaiyi Liu
Journal:  Precis Clin Med       Date:  2021-04-30

3.  [Tumor Margin Infiltration in Soft Tissue Sarcomas: Prediction Using 3T MRI Texture Analysis].

Authors:  Minji Kim; Won-Hee Jee; Youngjun Lee; Ji Hyun Hong; Chan Kwon Jung; Yang-Guk Chung; So-Yeon Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-09-16

4.  Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions.

Authors:  Jieying Zhang; Xiaoduo Yu; Xiaomiao Zhang; Shuang Chen; Yan Song; Lizhi Xie; Yan Chen; Han Ouyang
Journal:  BMC Med Imaging       Date:  2022-08-08       Impact factor: 2.795

5.  Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Fan Xu; Yingying Liang; Wei Guo; Zhiping Liang; Liqi Li; Yuchao Xiong; Guoxi Ye; Xuwen Zeng
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.